Rani Therapeutics Holdings, Inc. (RANI)

Rani Therapeutics Holdings, Inc. (RANI) is a healthcare company (biotechnology) based in the United States. The share price is $0.57, up 5.42% on the day, which values the company at $65.78M. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$0.57+5.42% today
Market value
$65.78M
Funk Score
29/100
Against its own history
Well below its usual priceusual price $2.32
200-week average
$2.3776% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Rani Therapeutics Holdings, Inc. in more detail

RANI trades at -3.0× next year's expected earnings, 10.0× sales. Measured against its own history, the price is 75% below what its usual multiples would imply ($2.32) — well below its usual price. It sits 76% below its 200-week average of $2.37.

Over the last five fiscal years Rani Therapeutics Holdings, Inc. has compounded revenue 28.7% a year. Its Funk Score is 29 out of 100 (financial strength 3.8, profitability 0.0, value 5.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Share count keeps rising.

2 of the superinvestors tracked here hold RANI, including Peter Kolchinsky (0.1% of the portfolio), Andrew Spokes (0.0% of the portfolio).

Superinvestors holding RANI

2 of the investors tracked here report a position in their latest 13F filing.

Rani Therapeutics Holdings, Inc. (RANI): questions and answers

What is Rani Therapeutics Holdings, Inc.'s market cap?

Rani Therapeutics Holdings, Inc. is valued at $65.78M at a share price of $0.57.

Is RANI overvalued or undervalued?

Against its own history, RANI is well below its usual price: the price is 75% below the $2.32 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is RANI above its 200-week moving average?

No. RANI is 76.0% below its 200-week average of $2.37. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Rani Therapeutics Holdings, Inc. growing?

Over the last five fiscal years Rani Therapeutics Holdings, Inc.'s revenue grew 28.7% a year.

Does RANI pay a dividend?

Rani Therapeutics Holdings, Inc. does not currently pay a regular dividend.

Which famous investors own RANI?

In their latest quarterly filings, Peter Kolchinsky (0.1% of the portfolio), Andrew Spokes (0.0% of the portfolio) hold RANI. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Rani Therapeutics Holdings, Inc. (RANI) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RANI

Underlying data: Yahoo Finance; company filings with the SEC.